Abstract
References
- Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of adult inpatients with CO- VID-19 in Wuhan, China: a retrospective cohort study. Lancet 2020; 395: 1054-62.
- Du Toit A. Outbreak of a novel coronavirus. Nat Rev Microbiol 2020; 18: 123.
- European Centre for Disease Prevention and Control. Q & A on COVID-19: Basic facts. Available from: https://www. ecdc.europa.eu/en/covid-19/facts/questions-answersbasic-facts Accessed date: 18 Sept 2020.
- Mahajan P, Dass B, Radhakrishnan N, McCullough PA. COVID-19-Associated Systemic Thromboembolism: A Case Report and Review of the Literature. Cardiorenal Med 2020; 10: 462-9.
- Boukhris M, Hillani A, Moroni F, et al. Cardiovascular Implications of the COVID-19 Pandemic: A Global Perspective. Can J Cardiol 2020; 36: 1068-80.
- Tian D, Ye Q. Hepatic complications of COVID-19 and its treatment. J Med Virol 2020; 92: 1818-24.
- Chen N, Zhou M, Dong X, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet 2020; 395: 507-13.
- Zantah M, Dominguez Castillo E, Townsend R, Dikengil F, Criner GJ. Pneumothorax in COVID-19 disease- incidence and clinical characteristics. Respir Res 2020; 21: 236.
- Jin JM, Bai P, He W, et al. Gender differences in patients with COVID-19: focus on severity and mortality. Front Public Health 2020; 8: 152.
- Qiu P, Zhou Y, Wang F, et al. Clinical characteristics, laboratory outcome characteristics, comorbidities, and complications of related COVID-19 deceased: a systematic review and meta-analysis. Aging Clin Exp Res 2020; 32: 1869-78.
- Bertolini A, Van de Peppel IP, Bodewes FAJA, Moshage H, Fantin A, Farinati F. Abnormal liver function tests in patients with COVID-19: Relevance and Potential Pathogenesis. Hepatology 2020; 72: 1864-72.
- Zhang Y, Zheng L, Liu L, Zhao M, Xiao J, Zhao Q. Liver impairment in COVID-19 patients: A retrospective analysis of 115 cases from a single centre in Wuhan city, China. Liver Int 2020; 40: 2095-103.
- Cai Q, Huang D, Yu H, et al. COVID-19: Abnormal liver function tests. J Hepatol 2020; 73: 566-74.
- Fan Z, Chen L, Li J, et al. Clinical features of COVID-19-related liver damage. Clin Gastroenterol Hepatol 2020; 18: 1561-6.
- Porfidia A, Valeriani E, Pola R, Porreca E, Rutjes A, Di Nisio M. Venous thromboembolism in patients with COVID-19: Systematic review and meta-analysis. Thrombosis research 2020; 196: 67-74.
- Boonyawat K, Chantrathammachart P, Numthavaj P, et al. Incidence of thromboembolism in patients with COVID-19: a systematic review and meta-analysis. Thrombosis Journal 2020: 23; 18: 34.
- Bompard F, Monnier H, Saab I et al. Pulmonary embolism in patients with COVID-19 pneumonia. Eur Respir J. 2020; 56: 2001365.
- Xu Y, Qian Y, Gu Q, et al. Relationship between d-dimer concentration and inflammatory factors or organ function in patients with coronavirus disease 2019. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue 2020; 32: 559–63.
- Li Y, Zhao K, Wei H, et al. Dynamic relationship between d-dimer and COVID-19 severity. Br J Haematol 2020; 190: e24–7.
- Middeldorp S, Coppens M, van Haaps TF, et al. Incidence of venous thromboembolism in hospitalized patients with COVID-19. J Thromb Haemost. 2020 Aug;18(8):1995-2002.
- Lodigiani C, Iapichino G, Carenzo L, et al. Venous and arterial thromboembolic complications in COVID-19 patients admitted to an academic hospital in Milan, Italy. Thromb Res 2020; 191: 9.
- Sun R, Liu H, Wang X. Mediastinal emphysema, Giant Bulla and pneumothorax developed during the course of COVID-19 pneumonia. Korean J Radiol 2020; 21: 541-44.
- Liu K, Zeng Y, Xie P, et al. COVID-19 with cystic features on computed tomography: A case report. Medicine (Baltimore) 2020; 99: e20175.
- Mohan S, Workman A, Barshak M, Welling DB, Abdul-Aziz D. Considerations in Management of Acute Otitis Media in the COVID-19 Era. Ann Otol Rhinol Laryngol 2021; 130: 520-27.
- Fidan V. New type of corona virus induced acute otitis media in adult. Am J Otolaryngol 2020; 41: 102487.
- Mao L, Jin H, Wang M, et al. Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China. JAMA Neurol 2020; 77: 683-90.
- Li Y, Li M, Wang M, et al. Acute cerebrovascular disease following COVID-19: a single center, retrospective, observational study. Stroke Vasc Neurol 2020; 5: 279-84.
Complications with moderate-to-severe COVID-19 during hospital admissions in patients with pneumonia
Abstract
Introduction: Coronavirus disease 2019 (COVID-19), caused by SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) is an infectious disease that has caused significant mortality and morbidity worldwide. COVID-19 is known to cause complications, such as myocardial damage, acute coronary syndrome, deep vein thrombosis, pulmonary embolism, arrhythmia, heart failure, acute ischemic stroke, liver damage, cytokine storms, ischemia-reperfusion damage and side effects of drug treatments. In our study, we aimed to evaluate the complications that developed during hospitalizations in patients with moderate-to-severe COVID-19 related pneumonia who were hospitalized in our COVID-19 service.
Material and Method: This study included patients with moderate-to-severe COVID-19 pneumonia with a positive reverse transcriptase polymerase chain reaction (RT-PCR) test who were treated in our COVID-19 service between November 2020 and January 2021. Their demographic characteristics, treatment regimens, baseline laboratory values and complications during their hospitalization were retrospectively recorded.
Results: The study group had a mean age of 62.92± 14.60 years and 40.6% (n= 55) were female. Approximately 35.3% (n= 48) of the patients developed complications due to COVID-19 during their follow-up period. Of the patients with complications, 63.8% (n: 30) were male, most common complications were elevated liver enzymes (47.9%) and pulmonary thromboembolism (20.8%). Of those patients with complications, the most common comorbidities were hypertension (40.4% [n= 19]), diabetes mellitus (25.5% [n=12]) and cardiovascular disease (23.4% [n=11]). There were no significant relationships between the presence of complications and age, sex or comorbid diseases (p>0.05 for each).
Conclusion: There are more underlying conditions, such as hypertension, diabetes mellitus, cardiovascular disease, chronic lung disease in hospitalized patients with moderate-to-severe pneumonia compared to outpatients with COVID-19 pneumonia. Complications develop, especially in the management of COVID-19 pneumonia, which affect the treatment process and patient mobilization.
Keywords
References
- Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of adult inpatients with CO- VID-19 in Wuhan, China: a retrospective cohort study. Lancet 2020; 395: 1054-62.
- Du Toit A. Outbreak of a novel coronavirus. Nat Rev Microbiol 2020; 18: 123.
- European Centre for Disease Prevention and Control. Q & A on COVID-19: Basic facts. Available from: https://www. ecdc.europa.eu/en/covid-19/facts/questions-answersbasic-facts Accessed date: 18 Sept 2020.
- Mahajan P, Dass B, Radhakrishnan N, McCullough PA. COVID-19-Associated Systemic Thromboembolism: A Case Report and Review of the Literature. Cardiorenal Med 2020; 10: 462-9.
- Boukhris M, Hillani A, Moroni F, et al. Cardiovascular Implications of the COVID-19 Pandemic: A Global Perspective. Can J Cardiol 2020; 36: 1068-80.
- Tian D, Ye Q. Hepatic complications of COVID-19 and its treatment. J Med Virol 2020; 92: 1818-24.
- Chen N, Zhou M, Dong X, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet 2020; 395: 507-13.
- Zantah M, Dominguez Castillo E, Townsend R, Dikengil F, Criner GJ. Pneumothorax in COVID-19 disease- incidence and clinical characteristics. Respir Res 2020; 21: 236.
- Jin JM, Bai P, He W, et al. Gender differences in patients with COVID-19: focus on severity and mortality. Front Public Health 2020; 8: 152.
- Qiu P, Zhou Y, Wang F, et al. Clinical characteristics, laboratory outcome characteristics, comorbidities, and complications of related COVID-19 deceased: a systematic review and meta-analysis. Aging Clin Exp Res 2020; 32: 1869-78.
- Bertolini A, Van de Peppel IP, Bodewes FAJA, Moshage H, Fantin A, Farinati F. Abnormal liver function tests in patients with COVID-19: Relevance and Potential Pathogenesis. Hepatology 2020; 72: 1864-72.
- Zhang Y, Zheng L, Liu L, Zhao M, Xiao J, Zhao Q. Liver impairment in COVID-19 patients: A retrospective analysis of 115 cases from a single centre in Wuhan city, China. Liver Int 2020; 40: 2095-103.
- Cai Q, Huang D, Yu H, et al. COVID-19: Abnormal liver function tests. J Hepatol 2020; 73: 566-74.
- Fan Z, Chen L, Li J, et al. Clinical features of COVID-19-related liver damage. Clin Gastroenterol Hepatol 2020; 18: 1561-6.
- Porfidia A, Valeriani E, Pola R, Porreca E, Rutjes A, Di Nisio M. Venous thromboembolism in patients with COVID-19: Systematic review and meta-analysis. Thrombosis research 2020; 196: 67-74.
- Boonyawat K, Chantrathammachart P, Numthavaj P, et al. Incidence of thromboembolism in patients with COVID-19: a systematic review and meta-analysis. Thrombosis Journal 2020: 23; 18: 34.
- Bompard F, Monnier H, Saab I et al. Pulmonary embolism in patients with COVID-19 pneumonia. Eur Respir J. 2020; 56: 2001365.
- Xu Y, Qian Y, Gu Q, et al. Relationship between d-dimer concentration and inflammatory factors or organ function in patients with coronavirus disease 2019. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue 2020; 32: 559–63.
- Li Y, Zhao K, Wei H, et al. Dynamic relationship between d-dimer and COVID-19 severity. Br J Haematol 2020; 190: e24–7.
- Middeldorp S, Coppens M, van Haaps TF, et al. Incidence of venous thromboembolism in hospitalized patients with COVID-19. J Thromb Haemost. 2020 Aug;18(8):1995-2002.
- Lodigiani C, Iapichino G, Carenzo L, et al. Venous and arterial thromboembolic complications in COVID-19 patients admitted to an academic hospital in Milan, Italy. Thromb Res 2020; 191: 9.
- Sun R, Liu H, Wang X. Mediastinal emphysema, Giant Bulla and pneumothorax developed during the course of COVID-19 pneumonia. Korean J Radiol 2020; 21: 541-44.
- Liu K, Zeng Y, Xie P, et al. COVID-19 with cystic features on computed tomography: A case report. Medicine (Baltimore) 2020; 99: e20175.
- Mohan S, Workman A, Barshak M, Welling DB, Abdul-Aziz D. Considerations in Management of Acute Otitis Media in the COVID-19 Era. Ann Otol Rhinol Laryngol 2021; 130: 520-27.
- Fidan V. New type of corona virus induced acute otitis media in adult. Am J Otolaryngol 2020; 41: 102487.
- Mao L, Jin H, Wang M, et al. Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China. JAMA Neurol 2020; 77: 683-90.
- Li Y, Li M, Wang M, et al. Acute cerebrovascular disease following COVID-19: a single center, retrospective, observational study. Stroke Vasc Neurol 2020; 5: 279-84.
Details
| Primary Language | English |
|---|---|
| Subjects | Health Care Administration |
| Journal Section | Original Article |
| Authors | |
| Publication Date | September 24, 2021 |
| Published in Issue | Year 2021 Volume: 4 Issue: 6 |
Cited By
The effect of immunosuppressive therapy on the development of ventilator-associated pneumonia in patients with COVID-19
Journal of Health Sciences and Medicine
https://doi.org/10.32322/jhsm.1136479
The comparison of chest X-ray and CT visibility according to size and lesion types in the patients with COVID-19
Journal of Health Sciences and Medicine
https://doi.org/10.32322/jhsm.1100231
Outcomes of patients with COVID-19 pneumonia treated with moderate and high dose corticosteroids
Anatolian Current Medical Journal
https://doi.org/10.38053/acmj.1099212
Our convalescent plasma experiences in COVID-19 patients hospitalized in the intensive care unit
Journal of Health Sciences and Medicine
https://doi.org/10.32322/jhsm.1068864
Medical device related pressure injuries in COVID-19 patients followed up in an intensive care unit
Journal of Health Sciences and Medicine
https://doi.org/10.32322/jhsm.1011537
Comparison of demographic and laboratory data of young and elderly patients who deceased due to COVID-19
Journal of Health Sciences and Medicine
https://doi.org/10.32322/jhsm.1047413
Interuniversity Board (UAK) Equivalency: Article published in Ulakbim TR Index journal [10 POINTS], and Article published in other (excuding 1a, b, c) international indexed journal (1d) [5 POINTS].
The Directories (indexes) and Platforms we are included in are at the bottom of the page.
Note: Our journal is not WOS indexed and therefore is not classified as Q.
You can download Council of Higher Education (CoHG) [Yüksek Öğretim Kurumu (YÖK)] Criteria) decisions about predatory/questionable journals and the author's clarification text and journal charge policy from your browser. https://dergipark.org.tr/tr/journal/2316/file/4905/show
The indexes of the journal are ULAKBİM TR Dizin, Index Copernicus, ICI World of Journals, DOAJ, Directory of Research Journals Indexing (DRJI), General Impact Factor, ASOS Index, WorldCat (OCLC), MIAR, EuroPub, OpenAIRE, Türkiye Citation Index, Türk Medline Index, InfoBase Index, Scilit, etc.
|
|
|
| |
|
|
|
|
The platforms of the journal are Google Scholar, CrossRef (DOI), ResearchBib, Open Access, COPE, ICMJE, NCBI, ORCID, Creative Commons, etc.
|
|
|
|
|
|
Our Journal using the DergiPark system indexed are;
Ulakbim TR Dizin, Index Copernicus, ICI World of Journals, Directory of Research Journals Indexing (DRJI), General Impact Factor, ASOS Index, OpenAIRE, MIAR, EuroPub, WorldCat (OCLC), DOAJ, Türkiye Citation Index, Türk Medline Index, InfoBase Index
Our Journal using the DergiPark system platforms are;
Journal articles are evaluated as "Double-Blind Peer Review".
Our journal has adopted the Open Access Policy and articles in JHSM are Open Access and fully comply with Open Access instructions. All articles in the system can be accessed and read without a journal user. https//dergipark.org.tr/tr/pub/jhsm/page/9535
Journal charge policy https://dergipark.org.tr/tr/pub/jhsm/page/10912
Editor List for 2022
Assoc. Prof. Alpaslan TANOĞLU (MD)
Prof. Aydın ÇİFCİ (MD)
Prof. İbrahim Celalaettin HAZNEDAROĞLU (MD)
Prof. Murat KEKİLLİ (MD)
Prof. Yavuz BEYAZIT (MD)
Prof. Ekrem ÜNAL (MD)
Prof. Ahmet EKEN (MD)
Assoc. Prof. Ercan YUVANÇ (MD)
Assoc. Prof. Bekir UÇAN (MD)
Assoc. Prof. Mehmet Sinan DAL (MD)
Our journal has been indexed in DOAJ as of May 18, 2020.
Our journal has been indexed in TR-Dizin as of March 12, 2021.
Articles published in the Journal of Health Sciences and Medicine have open access and are licensed under the Creative Commons CC BY-NC-ND 4.0 International License.